These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22015636)

  • 1. Optimizing immunosuppressive drug dosing in pediatric renal transplantation. Part of a special series on Paediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni.
    Cattaneo D; Vinks AA
    Pharmacol Res; 2012 Feb; 65(2):163-7. PubMed ID: 22015636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of pharmacotherapy in the prevention and treatment of paediatric metabolic syndrome--Implications for long-term health: part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni.
    Sabin MA; Magnussen CG; Juonala M; Cowley MA; Shield JP
    Pharmacol Res; 2012 Apr; 65(4):397-401. PubMed ID: 22037094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic therapy of heart failure in children: part of a special series on paediatric pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni.
    Timberlake K; Kantor PF
    Pharmacol Res; 2011 Nov; 64(5):427-30. PubMed ID: 21708258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From pharmacovigilance to therapy amelioration in paediatric patients: the role of the clinical pharmacologists and family paediatricians. Part of a series on Paediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni.
    Napoleone E; Radice S
    Pharmacol Res; 2012 Feb; 65(2):168-70. PubMed ID: 21983004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2050: Ending the odyssey of the great white plague. Part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni.
    Jassal MS; Aldrovandi GM
    Pharmacol Res; 2011 Sep; 64(3):176-9. PubMed ID: 21540112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of medicines for children. Part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni.
    Rocchi F; Tomasi P
    Pharmacol Res; 2011 Sep; 64(3):169-75. PubMed ID: 21376810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes and beans: pharmacogenomics of renal transplant.
    Murray B; Hawes E; Lee RA; Watson R; Roederer MW
    Pharmacogenomics; 2013 May; 14(7):783-98. PubMed ID: 23651025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutics in pediatric diabetes: insulin and non-insulin approaches. Part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni.
    Kim J; Kim SM; Nguyen HC; Redondo MJ
    Pharmacol Res; 2012 Jan; 65(1):1-4. PubMed ID: 21930210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Bergamo Kidney Transplant Program.
    Perico N; Cravedi P; Ruggenenti P; Gotti E; Rota G; Locatelli G; Gambara V; Perna A; Rota S; Remuzzi G
    Clin Transpl; 2005; ():85-100. PubMed ID: 17424727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Projecting long-term graft and patient survival after transplantation.
    Levy AR; Briggs AH; Johnston K; MacLean JR; Yuan Y; L'Italien GJ; Kalsekar A; Schnitzler MA
    Value Health; 2014 Mar; 17(2):254-60. PubMed ID: 24636384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in pediatric transplantation: the impact of chronic kidney disease and cardiovascular risk factors on long-term outcomes and recommended management strategies.
    Filler G
    Pediatr Transplant; 2011 Feb; 15(1):25-31. PubMed ID: 21155958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current progress in pharmacogenetics and individualized immunosuppressive drug dosing in organ transplantation.
    Ware N; MacPhee IA
    Curr Opin Mol Ther; 2010 Jun; 12(3):270-83. PubMed ID: 20521216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving long-term renal transplant outcomes with tacrolimus: speculation vs evidence.
    First MR
    Nephrol Dial Transplant; 2004 Dec; 19 Suppl 6():vi17-vi22. PubMed ID: 15575022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment optimization of maintenance immunosuppressive agents in pediatric renal transplant recipients.
    Job KM; Roberts JK; Enioutina EY; Illamola SM; Kumar SS; Rashid J; Ward RM; Fukuda T; Sherbotie J; Sherwin CM
    Expert Opin Drug Metab Toxicol; 2021 Jul; 17(7):747-765. PubMed ID: 34121566
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteristics of long-term immunosuppressive therapy in Chinese pediatric renal transplant patients: a single-center experience.
    Yang S; Wu Z; Wu W; Lin W; Xu T; Cai J; Wang Q; Liao L; Tan J
    Transplant Proc; 2009 Dec; 41(10):4169-71. PubMed ID: 20005361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation.
    Tönshoff B; David-Neto E; Ettenger R; Filler G; van Gelder T; Goebel J; Kuypers DR; Tsai E; Vinks AA; Weber LT; Zimmerhackl LB
    Transplant Rev (Orlando); 2011 Apr; 25(2):78-89. PubMed ID: 21454065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney transplantation at the University of Illinois at Chicago from 1988-2004.
    Oberholzer J; Testa G; Sankary H; John E; Thielke J; Benedetti E
    Clin Transpl; 2004; ():143-9. PubMed ID: 16704147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of intensive initial immunosuppression protocol in pediatric deceased donor renal transplantation.
    Olaitan OK; Zimmermann JA; Shields WP; Rodriguez-Navas G; Awan A; Mohan P; Little DM; Hickey DP
    Pediatr Transplant; 2010 Feb; 14(1):87-92. PubMed ID: 19309452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.